Skip to main content
. 2021 Jun 25;11:13348. doi: 10.1038/s41598-021-92587-0

Table 5.

Association between serum levels of biomarkers, progression and mortality.

Progression p Death p
Yes No Yes No
IL-1 6.1 (4.3) 7.4 (16.0) 0.372 6.2 (4.4) 7.1 (14.0) 0.608
IL-2R 428.4 (258.5) 445.9 (248.4) 0.534 501.2 (312.4) 424.5 (234.1) 0.067
IL-6 8.7 (9.6) 7.9 (8.6) 0.429 11.1 (8.7) 7.5 (8.9) 0.004*
IL-8 44.7 (38.9) 30.7 (36.5) 0.001* 58.2 (50.4) 30.1 (29.1) 0.001*
TNF-α 7.9 (21.2) 7.0 (14.9) 0.669 7.6 (21.l) 7.3 (16.8) 0.896
TGF-β 20.5 (7.7) 19.9 (7.3) 0.493 19.7(7.2) 20.2 (7.5) 0.650
LDH 400.6 (107.1) 364.3 (91.5) 0.001* 445.5 (124.7) 363.4 (84.7)  < 0.001**
Alpha1AT 148.9 (35.6) 138.5 (36.1) 0.011* 173.2 (38.1) 135.7 (31.5)  < 0.001**
Ferritin 549.3 (519.3) 471.4 (469.0) 0.217 871.4 (866.4) 432.2 (335.4) 0.003*
CRP 12.1 (16.7) 9.5 (18.4) 0.202 20.9 (23.0) 8.0 (15.3)  < 0.001**

IL1β Interleukin 1 beta, IL2R interleukin 2 receptor subunit alpha, IL-6 Interleukin 6, IL-8 interleukin 8, TNF-α Tumour necrosis factor alpha, TGF-β1 Transforming growth factor-beta 1, AAT alpha-1 antitrypsin, LDH lactate dehydrogenase, CRP C-reactive protein.

Statistical significance was determined using χ2 test and T Student test for qualitative and continuous variables, respectively.

*p < 0.05; **p < 0.001.